University of Maryland School of Medicine to take part in landmark Zika vaccine study

(University of Maryland School of Medicine) The Center for Vaccine Development at the University of Maryland School of Medicine's Institute for Global Health has been chosen as one of three study sites in a human safety trial of a new Zika vaccine. The early-stage study will evaluate the experimental vaccine's safety and ability to generate an immune system response in participants.